Development and validation of a polygenic risk score predicts type 1 diabetes risk across ancestries, suggesting broad application for screening.
We developed a trans-ancestry PRS that outperformed the European-based GRS2x. Importantly, TA-PS provides a comparable prediction in various ancestries, which supports its use in population-wide screening programmes.
No takes yet. Share an insight, caveat, or question.
Jumentier et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: